Comparison of Demographic and Clinicopathological Characteristics of Basal Cell Carcinoma on the Nose and Other Sites of the Face: A Cross-Sectional Study.
Basal cell carcinoma
Face
Nose
Perineural invasion
Journal
Iranian journal of otorhinolaryngology
ISSN: 2251-7251
Titre abrégé: Iran J Otorhinolaryngol
Pays: Iran
ID NLM: 101577699
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
09
04
2020
accepted:
03
07
2021
entrez:
25
10
2021
pubmed:
26
10
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
The clinicopathological characteristics of basal cell carcinoma (BCC) in different areas of the face, including the nose, are important and may be different. Accurate recognition of these characteristics may be necessary for the planning and selection of appropriate treatment. This cross-sectional study was conducted on 328 patients (131 females and 197 males) with 371 documented facial BCC in the West of Iran within 2013-2018. The demographic and clinicopathological data of the patients in the nose area were compared with other sites of the face by appropriate statistical methods. Out of 371 lesions, 38.8% of the cases were on the nose, 75.8% were primary lesions, 97.8% had no perineural invasion, 89.2% were nodular, and 65.8% were of nodular clinical and pathologic type, which were the most common variables of patients. It was revealed that early-onset (P<0.001), smaller size (P<0.001), high-risk pathologic type (P=0.01), and recurrent lesions (P=0.013) were significantly higher in the nasal BCC. However, there was no significant difference between BCC in the nose and other sites of the face in terms of gender (P=0.654), high-risk clinical type (P=0.06), and perineural invasion (P=0.275). Considering the nasal site as an important cosmetic unit, more limitation of the nose in performing any procedure, and presence of the more risk factors in the nose than in other areas of the face, the definite treatment of nasal BCC requires special attention, expertise, and experience.
Identifiants
pubmed: 34692572
doi: 10.22038/ijorl.2021.47720.2575
pmc: PMC8507944
doi:
Types de publication
Journal Article
Langues
eng
Pagination
257-262Références
Exp Dermatol. 2019 Feb;28 Suppl 1:69-71
pubmed: 30698878
J Skin Cancer. 2012;2012:943472
pubmed: 23316370
G Ital Dermatol Venereol. 2015 Aug;150(4):385-91
pubmed: 26099353
J Skin Cancer. 2014;2014:173582
pubmed: 25530883
Acta Dermatovenerol Alp Pannonica Adriat. 2013 Sep;22(3):57-61
pubmed: 24089133
J Skin Cancer. 2018 Oct 4;2018:2624054
pubmed: 30498602
Cancer. 2000 Apr 1;88(7):1605-13
pubmed: 10738219
Arch Dermatol. 2010 Aug;146(8):848-55
pubmed: 20713815
Facial Plast Surg. 2002 Nov;18(4):209-14
pubmed: 12524592
An Bras Dermatol. 2010 Nov-Dec;85(6):819-26
pubmed: 21308305
Br J Dermatol. 2019 Sep;181(3):474-482
pubmed: 30864158
Dermatol Reports. 2018 Dec 04;10(2):7674
pubmed: 30603060
J Cutan Aesthet Surg. 2014 Jul;7(3):143-50
pubmed: 25538434
Postepy Dermatol Alergol. 2018 Feb;35(1):47-52
pubmed: 29599671
An Bras Dermatol. 2011 Mar-Apr;86(2):386-8
pubmed: 21603832
Braz J Otorhinolaryngol. 2017 Jan - Feb;83(1):94-97
pubmed: 27160472
Facial Plast Surg. 2010 Aug;26(4):320-7
pubmed: 20665410
Br J Dermatol. 2016 Jun;174(6):1258-65
pubmed: 26872563